TrademarkOpen
Search / United States / 97855498

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

IRIS

Registered
Used for: Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA…
Show more

Class 1: Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases
Class 5: Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases
Class 42: Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology

Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 28 Mar 2023
    Application filed
    New Application Entered
  2. 14 Sep 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 3 Oct 2023
    Office action issued
    Non-Final Action Written
  4. 22 Dec 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 29 Jan 2024
    Final refusal issued
    Final Refusal Mailed
  6. 25 Oct 2024
    Approved for publication
    Approved For Pub - Principal Register
  7. 28 Jan 2025
    Published for opposition
    Published For Opposition
  8. 18 Mar 2025
    Registered on the Principal Register
    Registered-Principal Register
All 35 events
2025-03-18Registered-Principal Register
2025-03-18Notice Of Registration Confirmation Emailed
2025-01-28Published For Opposition
2025-01-28Official Gazette Publication Confirmation E-Mailed
2025-01-22Notification Of Notice Of Publication E-Mailed
2024-10-25Teas/Email Correspondence Entered
2024-10-25Approved For Pub - Principal Register
2024-10-25Exparte Appeal Terminated
2024-07-29Exparte Appeal Received At Ttab
2024-07-29Jurisdiction Restored To Examining Attorney
2024-07-29Ex Parte Appeal-Instituted
2024-07-29Teas Request For Reconsideration Received
2024-07-29Correspondence Received In Law Office
2024-07-12Teas Voluntary Amendment Received
2024-07-12Preliminary/Voluntary Amendment - Entered
2024-04-23Application Extension To Response Period - Received
2024-04-23Application Extension Granted/Receipt Provided
2024-01-29Final Refusal Mailed
2024-01-29Final Refusal E-Mailed
2024-01-29Notification Of Final Refusal Emailed
2023-12-23Teas/Email Correspondence Entered
2023-12-22Teas Response To Office Action Received
2023-12-22Correspondence Received In Law Office
2023-10-03Non-Final Action Written
2023-10-03Non-Final Action E-Mailed
2023-10-03Notification Of Non-Final Action E-Mailed
2023-09-29Notice Of Acceptance Of Amendment To Allege Use E-Mailed
2023-09-28Use Amendment Accepted
2023-09-23Use Amendment Filed
2023-09-23Amendment To Use Processing Complete
2023-09-22Teas Amendment Of Use Received
2023-09-14Assigned To Examiner
2023-04-18Notice Of Design Search Code E-Mailed
2023-04-16New Application Office Supplied Data Entered
2023-03-28New Application Entered

Goods & services by class

Class 1 Chemicals

Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases

First use anywhere 9 Aug 2023 · First use in commerce 9 Aug 2023

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases

First use anywhere 9 Aug 2023 · First use in commerce 9 Aug 2023

Class 42 Technology & SaaS

Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology

First use anywhere 13 Jun 2023 · First use in commerce 13 Jun 2023

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 18 Mar 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.